{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:11:49Z","timestamp":1782180709980,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","award":["RD16\/0001\/0011"],"award-info":[{"award-number":["RD16\/0001\/0011"]}]},{"name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","award":["CD19\/00137"],"award-info":[{"award-number":["CD19\/00137"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79961-4","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T18:33:39Z","timestamp":1735583619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Untangling areas of improvement in secondary prevention of ischemic stroke in patients with atrial fibrillation"],"prefix":"10.1038","volume":"14","author":[{"given":"F","family":"S\u00e1nchez-S\u00e1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CL","family":"Rodr\u00edguez-Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Riera-Arnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Garcia-Sempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Peir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Sanf\u00e9lix-Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"79961_CR1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1459\u20131544. https:\/\/doi.org\/10.1016\/S0140-6736(16)31012-1 (2016).","journal-title":"Lancet"},{"key":"79961_CR2","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","volume":"380","author":"CJL Murray","year":"2012","unstructured":"Murray, C. J. L. et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2197\u20132223. https:\/\/doi.org\/10.1016\/S0140-6736(12)61689-4 (2012).","journal-title":"Lancet"},{"key":"79961_CR3","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/S0140-6736(04)16405-2","volume":"363","author":"PM Rothwell","year":"2004","unstructured":"Rothwell, P. M. et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363, 1925\u20131933. https:\/\/doi.org\/10.1016\/S0140-6736(04)16405-2 (2004).","journal-title":"Lancet"},{"key":"79961_CR4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0140-6736(16)31257-0","volume":"388","author":"B Freedman","year":"2016","unstructured":"Freedman, B., Potpara, T. S. & Lip, G. Y. H. Stroke prevention in atrial fibrillation. Lancet 388, 806\u2013817. https:\/\/doi.org\/10.1016\/S0140-6736(16)31257-0 (2016).","journal-title":"Lancet"},{"key":"79961_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/2396987319841187","volume":"4","author":"CJ Klijn","year":"2019","unstructured":"Klijn, C. J. et al. Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline. Eur. Stroke J. 4, 198\u2013223. https:\/\/doi.org\/10.1177\/2396987319841187 (2019).","journal-title":"Eur. Stroke J."},{"key":"79961_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1474-4422(18)30356-9","volume":"18","author":"DJ Seiffge","year":"2019","unstructured":"Seiffge, D. J. et al. Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol. 18, 117\u2013126. https:\/\/doi.org\/10.1016\/S1474-4422(18)30356-9 (2019).","journal-title":"Lancet Neurol."},{"key":"79961_CR7","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof, P. et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 37, 2893\u20132962. https:\/\/doi.org\/10.1093\/eurheartj\/ehw210 (2016).","journal-title":"Eur. Heart J."},{"key":"79961_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.789783","author":"CL Rodr\u00edguez-Bernal","year":"2021","unstructured":"Rodr\u00edguez-Bernal, C. L. et al. Real-world management and clinical outcomes of stroke survivors with atrial fibrillation: A population-based cohort in Spain. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.789783 (2021).","journal-title":"Front. Pharmacol."},{"key":"79961_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"CT January","year":"2019","unstructured":"January, C. T. et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: A report of the american college of cardiology\/american heart association task force on clinical practice guidelines and the heart rhythm society. J. Am. Coll. Cardiol. 74, 104\u2013132. https:\/\/doi.org\/10.1016\/j.jacc.2019.01.011 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"79961_CR10","doi-asserted-by":"publisher","first-page":"e025102","DOI":"10.1136\/bmjopen-2018-025102","volume":"8","author":"CL Rodr\u00edguez-Bernal","year":"2018","unstructured":"Rodr\u00edguez-Bernal, C. L. et al. Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis. BMJ Open 8, e025102. https:\/\/doi.org\/10.1136\/bmjopen-2018-025102 (2018).","journal-title":"BMJ Open"},{"key":"79961_CR11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens, B. et al. A new taxonomy for describing and defining adherence to medications. Br. J. Clin. Pharmacol. 73, 691\u2013705. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04167.x (2012).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"79961_CR12","doi-asserted-by":"publisher","first-page":"e005969","DOI":"10.1161\/CIRCOUTCOMES.119.005969","volume":"13","author":"AF Ozaki","year":"2020","unstructured":"Ozaki, A. F. et al. Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation. Circul. Cardiovasc. Qual. Outcomes 13, e005969 (2020).","journal-title":"Circul. Cardiovasc. Qual. Outcomes"},{"key":"79961_CR13","unstructured":"World Health Organization. Adherence to long-term therapies : evidence for action. https:\/\/iris.who.int\/handle\/10665\/42682 (2003)."},{"key":"79961_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg, L. & Blaschke, T. Adherence to medication. N. Engl. J. Med. 353, 487\u2013497. https:\/\/doi.org\/10.1056\/NEJMra050100 (2005).","journal-title":"N. Engl. J. Med."},{"key":"79961_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00213.x","author":"C Ja","year":"2008","unstructured":"Ja, C. et al. Medication compliance and persistence: terminology and definitions. Value Health J. Int. Soc. Pharmacoecon. Outcomes Res. https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00213.x (2008).","journal-title":"Value Health J. Int. Soc. Pharmacoecon. Outcomes Res."},{"key":"79961_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.07.032","volume":"24","author":"R Sauer","year":"2015","unstructured":"Sauer, R. et al. Adherence to oral anticoagulation in secondary stroke prevention\u2013the first year of direct oral anticoagulants. J. Stroke Cerebrovasc. Dis. 24, 78\u201382. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.07.032 (2015).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"79961_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000371574","volume":"73","author":"C Gumbinger","year":"2015","unstructured":"Gumbinger, C. et al. Reasons underlying non-adherence to and discontinuation of anticoagulation in secondary stroke prevention among patients with atrial fibrillation. Eur. Neurol. 73, 184\u2013191. https:\/\/doi.org\/10.1159\/000371574 (2015).","journal-title":"Eur. Neurol."},{"key":"79961_CR18","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyz266","volume":"49","author":"A Garc\u00eda-Sempere","year":"2020","unstructured":"Garc\u00eda-Sempere, A. et al. Data resource profile: the Valencia health system integrated database (VID). Int. J. Epidemiol 49, 740\u2013741e. https:\/\/doi.org\/10.1093\/ije\/dyz266 (2020).","journal-title":"Int. J. Epidemiol"},{"key":"79961_CR19","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, version 4.1.0. https:\/\/www.R-project.org\/. (2021)."},{"key":"79961_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01353","author":"I Hurtado-Navarro","year":"2018","unstructured":"Hurtado-Navarro, I. et al. Estimating adherence based on prescription or dispensation information: impact on thresholds and outcomes. A real-world study with atrial fibrillation patients treated with oral anticoagulants in Spain. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2018.01353 (2018).","journal-title":"Front. Pharmacol."},{"key":"79961_CR21","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s00415-019-09660-y","volume":"268","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Post-stroke medication adherence and persistence rates: a meta-analysis of observational studies. J. Neurol. 268, 2090\u20132098. https:\/\/doi.org\/10.1007\/s00415-019-09660-y (2021).","journal-title":"J. Neurol."},{"key":"79961_CR22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","volume":"5","author":"MJ Stirratt","year":"2015","unstructured":"Stirratt, M. J. et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl. Behav. Med. 5, 470\u2013482. https:\/\/doi.org\/10.1007\/s13142-015-0315-2 (2015).","journal-title":"Transl. Behav. Med."},{"key":"79961_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jval.2018.08.006","volume":"22","author":"PP Pednekar","year":"2019","unstructured":"Pednekar, P. P. et al. Methods for measuring multiple medication adherence: A systematic review-report of the ISPOR medication adherence and persistence special interest group. Value Health 22, 139\u2013156. https:\/\/doi.org\/10.1016\/j.jval.2018.08.006 (2019).","journal-title":"Value Health"},{"issue":"8","key":"79961_CR24","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.107.706820","volume":"117","author":"CA Jackevicius","year":"2008","unstructured":"Jackevicius, C. A., Li, P. & Tu, J. V. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 117(8), 1028\u20131036 (2008).","journal-title":"Circulation"},{"issue":"5","key":"79961_CR25","first-page":"440","volume":"24","author":"CL Rodriguez-Bernal","year":"2018","unstructured":"Rodriguez-Bernal, C. L., Peir\u00f3, S., Hurtado, I., Garc\u00eda-Sempere, A. & Sanf\u00e9lix-Gimeno, G. Primary nonadherence to oral anticoagulants in patients with atrial fibrillation: Real-world data from a population-based cohort. J. Manag. Care Spec. Pharm. 24(5), 440\u2013448 (2018).","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"22","key":"79961_CR26","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1056\/NEJMsa1107913","volume":"365","author":"NK Choudhry","year":"2011","unstructured":"Choudhry, N. K. et al. Post-myocardial infarction free rx event and economic evaluation (MI FREEE) trial. Full coverage for preventive medications after myocardial infarction. N. Engl. J. Med. 365(22), 2088\u20132097. https:\/\/doi.org\/10.1056\/NEJMsa1107913 (2011).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"79961_CR27","doi-asserted-by":"publisher","first-page":"11784","DOI":"10.1038\/s41598-017-10899-6","volume":"7","author":"A Garc\u00eda-Sempere","year":"2017","unstructured":"Garc\u00eda-Sempere, A. et al. Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study. Sci. Rep. 7(1), 11784. https:\/\/doi.org\/10.1038\/s41598-017-10899-6 (2017).","journal-title":"Sci. Rep."},{"key":"79961_CR28","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1212\/WNL.0b013e31822f0423","volume":"77","author":"CD Bushnell","year":"2011","unstructured":"Bushnell, C. D. et al. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology 77, 1182\u20131190. https:\/\/doi.org\/10.1212\/WNL.0b013e31822f0423 (2011).","journal-title":"Neurology"},{"key":"79961_CR29","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1037\/0022-3514.46.3.598","volume":"46","author":"DL Paulhus","year":"1984","unstructured":"Paulhus, D. L. Two-component models of socially desirable responding. J. Personal. Soc. Psychol. 46, 598\u2013609 (1984).","journal-title":"J. Personal. Soc. Psychol."},{"key":"79961_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.575634","author":"R Guti\u00e9rrez-Z\u00fa\u00f1iga","year":"2020","unstructured":"Guti\u00e9rrez-Z\u00fa\u00f1iga, R. et al. Long-term anticoagulation in secondary ischemic stroke prevention: The prospective multicenter RESTAIC registry. Front. Neurol. https:\/\/doi.org\/10.3389\/fneur.2020.575634 (2020).","journal-title":"Front. Neurol."},{"issue":"1","key":"79961_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","volume":"50","author":"JF Steiner","year":"1997","unstructured":"Steiner, J. F. & Prochazka, A. V. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J. Clin. Epidemiol. 50(1), 105\u2013116 (1997).","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"79961_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/01.mlr.0000207817.32496.cb","volume":"44","author":"R Grymonpre","year":"2006","unstructured":"Grymonpre, R., Cheang, M., Fraser, M., Metge, C. & Sitar, D. S. Validity of a prescription claims database to estimate medication adherence in older persons. Med. Care 44(5), 471\u2013477 (2006).","journal-title":"Med. Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79961-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79961-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79961-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T09:09:33Z","timestamp":1735636173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79961-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79961"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79961-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"9 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31596"}}